ReSTOR +3
DeviceBilateral implantation of ReSTOR +3 Intraocular Lenses (IOLs) after cataract extraction
NCT Number: NCT01166971
The purpose of this study is to prospectively evaluate postoperative visual and refractive parameters in a series of subjects bilaterally implanted with the AcrySof® IQ ReSTOR® +3 versus those bilaterally implanted with the Tecnis Multifocal 1-piece.
Looking for future studies?
Notify Me21 year and older
All sexes
Interventional
Phase 4
The Eye Center of North Florida, Panama City, Florida, United States
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Bilateral implantation of ReSTOR +3 Intraocular Lenses (IOLs) after cataract extraction
Bilateral implantation of Tecnis Multifocal (MF) Intraocular Lenses (IOLs) after cataract extraction
Time frame: 3 months after surgery
A defocus curve is created by multiple measurements of one's visual acuity at different spherical powers (recorded as Diopters (D)). Visual Acuity (VA) is measured in logMAR. LogMAR is the "logarithm of the minimum angle of resolution".
Alcon Research
Industry
A Randomized, Subject-masked Comparison of Visual Function After Bilateral Implantation of Presbyopia-correcting IOLs
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05411341
Cataract, Eye Diseases
Alexandroupoli, Evros, Greece
View Trial DetailsNCT06460389
Cataract, Eye Diseases
Alexandroupoli, Evros, Greece
View Trial DetailsNCT07385014
Cataract, Eye Diseases
Hershey, Pennsylvania, United States
View Trial DetailsNCT07008768
Cataract, Eye Diseases
Zagreb, Croatia
View Trial Details